We are live on ! Find out more
PAP

Persistent Asset Partners Portfolio holdings

AUM $335M
1-Year Est. Return 275.57%
This Fund
S&P 500
This Quarter Est. Return
+61.37%
1 Year Est. Return
+275.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$335M
AUM Growth
+$66.9M
Cap. Flow
-$37.3M
Cap. Flow %
-11.13%
Top 10 Hldgs %
34.76%
Holding
938
New
616
Increased
74
Reduced
90
Closed
134

Top Buys

Rank Stock Value
1
HOOD icon
Robinhood
HOOD
+$16M
2
STM icon
STMicroelectronics
STM
+$13.6M
3
APH icon
Amphenol
APH
+$10.9M
4
STX icon
Seagate
STX
+$7.07M
5
F icon
Ford
F
+$6.02M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$18.4M
2
LITE icon
Lumentum
LITE
+$14.5M
3
AXTI icon
AXT Inc
AXTI
+$13.3M
4
TSEM icon
Tower Semiconductor
TSEM
+$11.9M
5
MU icon
Micron Technology
MU
+$10.9M

Sector Composition

Rank Sector Weight
1 Technology 38.35%
2 Healthcare 29.66%
3 Financials 6.33%
4 Miscellaneous 6.14%
5 Consumer Discretionary 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYFW icon
876
First Western Financial
MYFW
$308M
– –
-34,520
Closed -$849K
OCGN icon
877
CALL
Ocugen
OCGN
$454M
– –
-758
Closed -$18.3K
OLMA icon
878
CALL
Olema Pharmaceuticals
OLMA
$947M
– –
-211
Closed -$1.15K
PASG icon
879
Passage Bio
PASG
$15.2M
– –
-4,955
Closed -$38.9K
PRAX icon
880
Praxis Precision Medicines
PRAX
$9.79B
– –
-1,131
Closed -$358K
PRTC
881
DELISTED
PureTech Health
PRTC
– –
-1,759
Closed -$26.1K
PSNL icon
882
Personalis
PSNL
$1.83B
– –
-20,929
Closed -$133K
QCRH icon
883
QCR Holdings
QCRH
$1.68B
– –
-11,693
Closed -$999K
QRVO icon
884
Qorvo
QRVO
$9.05B
– –
-30,096
Closed -$2.33M
RARE icon
885
Ultragenyx Pharmaceutical
RARE
$1.53B
– –
-8,884
Closed -$186K
RCKT icon
886
Rocket Pharmaceuticals
RCKT
$420M
– –
-7,731
Closed -$27.7K
REGN icon
887
Regeneron Pharmaceuticals
REGN
$85.6B
– –
-400
Closed -$309K
RKT icon
888
CALL
Rocket Companies
RKT
$39.7B
– –
-326
Closed -$30.9K
RKT icon
889
Rocket Companies
RKT
$39.7B
– –
-64,613
Closed -$921K
ROIV icon
890
PUT
Roivant Sciences
ROIV
$25.3B
– –
-860
Closed -$11.1K
RVMD icon
891
PUT
Revolution Medicines
RVMD
$44.8B
– –
-317
Closed -$90.5K
SDRL icon
892
Seadrill
SDRL
$3.06B
– –
-4,961
Closed -$223K
SE icon
893
Sea Limited
SE
$69.4B
– –
-3,000
Closed -$248K
SF
894
Stifel
SF
$12.3B
– –
-11,994
Closed -$887K
SFBS
895
ServisFirst Bancshares
SFBS
$4.73B
– –
-33,198
Closed -$1.21M
SLDB icon
896
Solid Biosciences
SLDB
$1.11B
– –
-27,990
Closed -$202K
SLV icon
897
PUT
iShares Silver Trust
SLV
$32.1B
– –
-28
Closed -$504
SMCI icon
898
PUT
Super Micro Computer
SMCI
$26.1B
– –
-83
Closed -$4.15K
SRZN icon
899
Surrozen
SRZN
$261M
– –
-7,143
Closed -$208K
SSB icon
900
SouthState Bank Corp
SSB
$10.5B
– –
-9,595
Closed -$888K
34 35
36
37 38

Similar funds

JWM
Jessup Wealth Management Dayton, Ohio $335M AUM 56.2% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $335M AUM 97.32% 1-Year Est. Return
TFA
TPG Financial Advisors Portland, Oregon $335M AUM 14.14% 1-Year Est. Return
SIM
Seaview Investment Managers Miami, Florida $335M AUM 47.2% 1-Year Est. Return
OWM
OneAscent Wealth Management Birmingham, Alabama $336M AUM 20.38% 1-Year Est. Return
SS
Spinecap SAS Paris, France $335M AUM 16.94% 1-Year Est. Return
BIA
BHK Investment Advisors Birmingham, Alabama $335M AUM 20.89% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $336M AUM 29.2% 1-Year Est. Return

Persistent Asset Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Persistent Asset Partners held 938 positions worth $335M, up 25% from $268M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Persistent Asset Partners withdrew a net $37.3M in Q2 2026, closing 134 positions and reducing 90 holdings. Its most notable exit was Lumentum, an estimated $14.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 38% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Persistent Asset Partners opened a new position in Robinhood worth $19.2M.

  • Persistent Asset Partners's largest Q2 2026 buy was Robinhood: 191,095 shares worth $19.2M.
  • Persistent Asset Partners added most to United Therapeutics in Q2 2026, an estimated $3.99M increase.
  • Persistent Asset Partners's biggest Q2 2026 reduction was Sandisk, cutting an estimated $18.4M.
  • Persistent Asset Partners fully exited Lumentum in Q2 2026, selling an estimated $14.5M.
  • Persistent Asset Partners's ten largest holdings make up 35% of its $335M portfolio in Q2 2026.
  • Persistent Asset Partners opened 616 new positions and closed 134 in Q2 2026.
  • Persistent Asset Partners's portfolio value rose 25% quarter-over-quarter to $335M.

Based on Persistent Asset Partners's 13F filing for Q2 2026, filed 7 Aug 2026.